Jeremy M. Levin, CEO at Ovid Therapeutics Inc. (OVID), bought 36,496 shares at $2.76 ($101K) on 2024-03-18, disclosed to the SEC on 2024-03-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.76 | 18,248 | $50K | 50.0% |
| 2 | $2.76 | 18,248 | $50K | 50.0% |
| Total | $2.76 avg | 36,496 | $101K | 100% |
| Filing → |
| OVID | BUY | 2019-02-26 | $150K | — | Filing → |
| OVID | BUY | 2017-08-28 | $219K | — | Filing → |